Integrated plasma multi-omics reveals stage-dependent immune–metabolic signatures and central carbon metabolism in early cognitive decline

The molecular changes distinguishing subjective cognitive decline (SCD) from mild cognitive impairment (MCI) are not well understood. We investigated baseline multi-omics signatures in cognitively normal participants to identify pathways and candidate biomarkers associated with subsequent cognitive outcomes. In a nested case-control study within a community cohort, we analyzed baseline plasma from 27 cognitively normal participants, 46 incident SCD cases, and 58 incident MCI cases using untargeted proteomics and metabolomics. Differential proteins and metabolites were identified using predefined fold change or variable importance in projection thresholds with Benjamini–Hochberg false discovery rate-adjusted P < 0.05. Pathway enrichment, clustering, weighted gene co-expression network analysis, and cross-omics integration were performed. Independent transcriptomic validation was conducted using a public dataset. Prediction models for SCD and MCI were developed using least absolute shrinkage and selection operator regression with age and sex. SCD was marked primarily by immune-related alterations, whereas MCI showed broader immune and metabolic disruption, particularly in amino acid and energy metabolism. Cross-omics integration identified central carbon metabolism as the main convergent pathway associated with MCI and the SCD versus MCI comparison. Fibroblast growth factor receptor 1, phosphoinositide-3-kinase regulatory subunit 2, L-leucine, L-serine, and pyruvic acid emerged as representative markers. Independent transcriptomic data supported pathway dysregulation. Integrative models achieved strong discrimination for both SCD and MCI. Baseline plasma multi-omics identified immune-metabolic signatures associated with subsequent cognitive outcomes and highlighted candidate pathways and molecular markers for future validation.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-14
DOI
https://doi.org/10.1186/s12967-026-09227-2
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated plasma multi-omics reveals stage-dependent immune–metabolic signatures and central carbon metabolism in early cognitive decline

YiMeng Wang, Dongshan Zhu, Zhen Qin, Chungang Zhai et al.
Journal of Translational Medicine
Dementia and Cognitive Impairment Research
article

Integrated plasma multi-omics reveals stage-dependent immune–metabolic signatures and central carbon metabolism in early cognitive decline

YiMeng Wang, Dongshan Zhu, Zhen Qin, Chungang Zhai, Bo Xie, Yiqing Liu, Yixuan Xie, Juan Li, Ruiqi Xu, Chunying Fu
article en

Abstract

The molecular changes distinguishing subjective cognitive decline (SCD) from mild cognitive impairment (MCI) are not well understood. We investigated baseline multi-omics signatures in cognitively normal participants to identify pathways and candidate biomarkers associated with subsequent cognitive outcomes. In a nested case-control study within a community cohort, we analyzed baseline plasma from 27 cognitively normal participants, 46 incident SCD cases, and 58 incident MCI cases using untargeted proteomics and metabolomics. Differential proteins and metabolites were identified using predefined fold change or variable importance in projection thresholds with Benjamini–Hochberg false discovery rate-adjusted P < 0.05. Pathway enrichment, clustering, weighted gene co-expression network analysis, and cross-omics integration were performed. Independent transcriptomic validation was conducted using a public dataset. Prediction models for SCD and MCI were developed using least absolute shrinkage and selection operator regression with age and sex. SCD was marked primarily by immune-related alterations, whereas MCI showed broader immune and metabolic disruption, particularly in amino acid and energy metabolism. Cross-omics integration identified central carbon metabolism as the main convergent pathway associated with MCI and the SCD versus MCI comparison. Fibroblast growth factor receptor 1, phosphoinositide-3-kinase regulatory subunit 2, L-leucine, L-serine, and pyruvic acid emerged as representative markers. Independent transcriptomic data supported pathway dysregulation. Integrative models achieved strong discrimination for both SCD and MCI. Baseline plasma multi-omics identified immune-metabolic signatures associated with subsequent cognitive outcomes and highlighted candidate pathways and molecular markers for future validation.

Journal of Translational Medicine
Shandong University (CN), Second Hospital of Shandong University (CN), Qilu Hospital of Shandong University (CN), Shandong First Medical University (CN), Second Affiliated Hospital of Xinjiang Medical University (CN)
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon